MEKONOS
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed technology company โ creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug discovery and development.
MEKONOS
Industry:
Biotechnology Life Science Nanotechnology Robotics Semiconductor
Founded:
2017-05-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.mekonos.com
Total Employee:
1+
Status:
Active
Total Funding:
31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag
Similar Organizations
Allevi
Allevi offers bioprinters that enable users to experiment with any biomaterial, work with any cell line, and print in any geometry.
Dice Therapeutics
Dice Therapeutics develops a transformative platform designed for the discovery of novel small molecules.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Kytopen
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Surface Oncology
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
Current Advisors List
Current Employees Featured
Founder
Investors List
Reimagined Ventures
Reimagined Ventures investment in Series A - Mekonos
TDK Ventures
TDK Ventures investment in Series A - Mekonos
Section 32
Section 32 investment in Series A - Mekonos
PEAK6 Investments LLC
PEAK6 Investments LLC investment in Series A - Mekonos
Novartis
Novartis investment in Series A - Mekonos
Sands Capital Ventures
Sands Capital Ventures investment in Series A - Mekonos
Fiscus Ventures
Fiscus Ventures investment in Series A - Mekonos
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series A - Mekonos
Elementum Ventures
Elementum Ventures investment in Series A - Mekonos
Elementum Ventures
Elementum Ventures investment in Seed Round - Mekonos
Official Site Inspections
http://www.mekonos.com Semrush global rank: 2.96 M Semrush visits lastest month: 5.49 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Mekonos"
Mekonos - Crunchbase Company Profile & Funding
Mekonos is a Silicon Valley Venture-backed technology company โ creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug โฆSee details»
Mekonos Inc. - LinkedIn
Building the future of cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed Life Sciences company โ creating a proprietary cell-engineering platform based on scalable silicon...See details»
Mekonos - The Org
Mekonos is a Silicon Valley Venture-backed technology company โ creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug โฆSee details»
Mekonos Company Profile 2024: Valuation, Funding & Investors
Developer of design systems and software intended to industrialize genome editing factories.See details»
Biotech Startup Mekonos raises oversubscribed $25 โฆ
Nov 9, 2021ย ยท Mekonos has developed a novel chip technology platform that supports ex-vivo delivery of cell payloads at the single cell level. The platform allows for multi-payload physical delivery โ...See details»
Mekonos Company Profile - Office Locations, Competitors ... - Craft
Mekonos is a technology company that designs systems and software. It develops a silicon chip infrastructure to deliver engineered therapies for genetic diseases including cancers, using โฆSee details»
Mekonos - VentureRadar
Mekonos is a nano robotics research and development company. The company is engaged in developing an approach of non-viral cell engineering by creating a patent pending silicon โฆSee details»
Mekonos - Contacts, Employees, Board Members, Advisors & Alumni
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.See details»
Mekonos - Funding, Financials, Valuation & Investors - Crunchbase
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.See details»
Mekonos closes Novartis-backed $25M series A for cell โฆ
Nov 9, 2021ย ยท Aiming to bypass that unwieldy technique is Mekonos, which is developing a cell engineering platform that uses silicon nanoneedles to deliver DNA, RNA or CRISPR molecules directly into individual...See details»
Mekonos Enters Partnership Agreement with Accelerated โฆ
May 2, 2024ย ยท ~ Mekonos' silicon nanoneedle-based delivery platform will provide Accelerated Bio with high efficiency, high viability cell engineering โ including the precise and gentle delivery of โฆSee details»
Mekonos raises $4.6M for its gene engineering platform - PR โฆ
Nov 23, 2020ย ยท Mekonos will use the new capital to accelerate the SoC platform for its current and new commercial partnerships. The SoC platform, with IP from Stanford University, is a โฆSee details»
Debiopharm's portfolio company Mekonos - Debiopharm
Mekonos is advancing a proprietary ex vivo cell engineering platform โ featuring microfluidics, microelectromechanical systems (MEMS) and surface chemistry โ for hyper-precise delivery โฆSee details»
Mekonos Raises $25 Million to Overcome Cell and Gene Therapy โฆ
Nov 10, 2021ย ยท Mekonos has developed a novel chip technology platform that supports ex vivo delivery of cell payloads at the single cell level. The platform allows for multi-payload physical โฆSee details»
Opentrons' subsidiary Neochromosome and Mekonos announce โฆ
Dec 14, 2021ย ยท Mekonos is an enabling technology company transforming synthetic biology and personalized medicine. The company's SoC merges innovations in MEMS, microfluidics, and โฆSee details»
Founder Spotlight #21: Anil Narasimha @ Mekonos - Medium
Jun 7, 2021ย ยท Anil Narasimha is Co-Founder & CEO @ Mekonos, a San Francisco-based company developing a platform for universal delivery of molecules into cells. After receiving โฆSee details»
Mekonos closes Novartis-backed $25M series A for cell โฆ
Nov 16, 2021ย ยท Aiming to bypass that unwieldy technique is Mekonos, which is developing a cell engineering platform that uses silicon nanoneedles to deliver DNA, RNA or CRISPR โฆSee details»
Mekonos - TDK Ventures
Nov 9, 2021ย ยท Learn about TDK Venturesโ role in empowering Mekonos to refine cell engineering with MEMS, paving the way for advanced therapies. Mekonos's innovative chip, built using โฆSee details»
Jobs at Mekonos | Elpha โ where women succeed at work together
Explore careers at Mekonos, connect with women who work at Mekonos, and read about the values that are part of Mekonos company culture.See details»
Greg Sitters - Co-Founder at Mekonos - The Org
Greg Sitters has a diverse work experience spanning several companies and roles. Greg is currently the Managing Partner at Matลซ Group, a venture fund focusing on early-stage Science โฆSee details»